Para depositar en Docta Complutense, identifícate con tu correo @ucm.es en el SSO institucional: Haz clic en el desplegable de INICIO DE SESIÓN situado en la parte superior derecha de la pantalla. Introduce tu correo electrónico y tu contraseña de la UCM y haz clic en el botón MI CUENTA UCM, no autenticación con contraseña.
 

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

dc.contributor.authorCarrasco Padilla, Carlos
dc.contributor.authorHernaiz Esteban, Alicia
dc.contributor.authorÁlvarez Vallina, Luis
dc.contributor.authorAguilar Sopeña, Óscar
dc.contributor.authorRoda Navarro, Pedro
dc.date.accessioned2023-06-22T11:20:46Z
dc.date.available2023-06-22T11:20:46Z
dc.date.issued2022-12-30
dc.description.abstractT cell-redirecting strategies have emerged as effective cancer immunotherapy approaches. Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor microenvironment and induce the assembly of the immunological synapse (IS) between T cells and cancer cells or antigen-presenting cells. The way that the quality of the IS might predict the effectiveness of T cell-redirecting strategies, including those mediated by bsAbs or by chimeric antigen receptors (CAR)-T cells, is currently under discussion. Here we review the organization of the canonical IS assembled during natural antigenic stimulation through the T cell receptor (TCR) and to what extent different bsAbs induce T cell activation, canonical IS organization, and effector function. Then, we discuss how the biochemical parameters of different formats of bsAbs affect the effectivity of generating an antigen-induced canonical IS. Finally, the quality of the IS assembled by bsAbs and monoclonal antibodies or CAR-T cells are compared, and strategies to improve bsAb-mediated T cell-redirecting strategies are discussed.
dc.description.departmentDepto. de Inmunología, Oftalmología y ORL
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia e Innovación (España)
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipFundación CRIS del Cáncer
dc.description.sponsorshipAsociación Española Contra el Cáncer
dc.description.sponsorshipFundación “La Caixa”
dc.description.sponsorshipFundación de Investigación Biomédica 12 de Octubre
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/78428
dc.identifier.doi10.3390/pharmaceutics15010132
dc.identifier.issn1999-4923
dc.identifier.officialurlhttps://doi.org/10.3390/pharmaceutics15010132
dc.identifier.relatedurlhttps://www.mdpi.com/journal/pharmaceutics
dc.identifier.urihttps://hdl.handle.net/20.500.14352/72336
dc.issue.number1
dc.journal.titlePharmaceutics
dc.language.isoeng
dc.page.initial132
dc.publisherMDPI
dc.relation.projectIDPID2020-115444GB-I00 ; PID2020-117323RB-100 y PDC2021-121711-100
dc.relation.projectIDDTS20/00089
dc.relation.projectIDFCRIS-2021-0090
dc.relation.projectIDPROYE19084ALVA
dc.relation.projectIDHR21-00761 IL7R_LungCan
dc.relation.projectIDPrograma Investiga (2022-0082)
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.cdu612.017
dc.subject.cdu616-006.04
dc.subject.keywordIS
dc.subject.keywordT cell
dc.subject.keywordImmunotherapy
dc.subject.keywordbsAb
dc.subject.keywordCAR
dc.subject.keywordTCR
dc.subject.ucmMedicina
dc.subject.ucmInmunología
dc.subject.ucmOncología
dc.subject.unesco32 Ciencias Médicas
dc.subject.unesco2412 Inmunología
dc.subject.unesco3201.01 Oncología
dc.titleBispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
dc.typejournal article
dc.volume.number15
dspace.entity.typePublication
relation.isAuthorOfPublication395f5345-8bac-41a2-a014-53c44bf97360
relation.isAuthorOfPublication.latestForDiscovery395f5345-8bac-41a2-a014-53c44bf97360

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pharmaceutics-15-00132.pdf
Size:
894.36 KB
Format:
Adobe Portable Document Format

Collections